熱門資訊> 正文
POET、PCSA和BRFH均为上市前涨幅股
2024-04-25 20:20
- POET Technologies Inc Ordinary Shares(POET) 0
- Processa Pharmaceuticals, Inc(PCSA) 0
- Barfresh Food Group Inc Ordinary Shares(BRFH) 0
- Gainers: Barfresh Food Group (NASDAQ:BRFH) +88%.
- Cyclacel Pharmaceuticals (CYCC) +50%.
- reAlpha (AIRE) +34%.
- Processa Pharmaceuticals (NASDAQ:PCSA) +31%.
- Cidara Therapeutics (CDTX) +16% rallies amid $240M private placement, drug update
- Ultralife (ULBI) +16% Q1 earnings call release
- Teradyne (TER) +9% Q1 earnings call release
- POET Technologies (NASDAQ:POET) +8%.
- TAL Education (TAL) +7% Q4 earnings call release
- Xiao-I (AIXI) +7%.
- Barclays (BCS) +6% Q1 earnings call release
- Unilever (UL) +6% Sales/ Trading Statement Call
- Laser Photonics (LASE) +6% Technology Meets Unique Cleaning Needs of Precision Optics Manufacturers
- ImmunityBio (IBRX) +6% shows positive overall survival in lung cancer trial
- Celestica (CLS) +6% Q1 earnings call release
- American Airlines Group (AAL) +6% TRASM and PRASM decline Q/Q and Y/Y as costs surge in Q1
- Deutsche Bank (DB) +6% reports 10%Y/Y growth in net profit; to increase share repurchases, dividends by at least 50% in 2024
- HashiCorp (HCP) +5% as Q1 results miss expectations; confirms HashiCorp deal
- Astrazeneca (AZN) +5% stock movers today: META, IBM, F, and more
-
More on premarket gainers & stock
- Barfresh Food Group, Inc. (BRFH) Q4 2023 Earnings Call Transcript
- POET: 2024 Could Be The Year For The Tide To Turn
- Processa Pharmaceuticals prices discounted stock and warrants offering to raise $7M
- Seeking Alpha’s Quant Rating on Barfresh Food Group
- Historical earnings data for Barfresh Food Group
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
